1401O Trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2-positive (HER2+) esophageal, gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 (DG-03)

Y. Y. Janjigian, Hanneke W.M. van Laarhoven, Sun Young Rha, V S Kozlov, D-Y. Oh, A. Gravina, L. Rapatoni, H. Shoji, R.D. Hofheinz, L-T. Chen, Hugo Ford, Maxime Chénard-Poirier, Saeed Raoufmoghaddam, C. Lloyd, Chi Zhang, C. Mateo, Jae Man Lee